Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.

Busse P, Zanichelli A, Bernstein JA, Anderson J, Betschel S, Castaner DN, Otule M, Piccolo T, Lumry WR

Open source

DOI
10.1007/s12016-026-09179-x
Published
2026 Aug 8
Container
Clinical reviews in allergy & immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12016-026-09179-x,
  title = {Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.},
  author = {Busse P and Zanichelli A and Bernstein JA and Anderson J and Betschel S and Castaner DN and Otule M and Piccolo T and Lumry WR},
  year = {2026},
  journal = {Clinical reviews in allergy \& immunology},
  doi = {10.1007/s12016-026-09179-x},
  url = {https://doi.org/10.1007/s12016-026-09179-x}
}

RIS

TY  - JOUR
TI  - Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.
AU  - Busse P
AU  - Zanichelli A
AU  - Bernstein JA
AU  - Anderson J
AU  - Betschel S
AU  - Castaner DN
AU  - Otule M
AU  - Piccolo T
AU  - Lumry WR
PY  - 2026
JO  - Clinical reviews in allergy & immunology
DO  - 10.1007/s12016-026-09179-x
UR  - https://doi.org/10.1007/s12016-026-09179-x
ER  - 

APA

P, B., A, Z., JA, B., J, A., S, B., DN, C., M, O., T, P., & WR, L. (2026). Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.. Clinical reviews in allergy & immunology. https://doi.org/10.1007/s12016-026-09179-x

Source records